Evidence map›Paper›PMID 28809082›Full record

ArticleMacromolecular bioscience2017

Development of a Dual-Functional Hydrogel Using RGD and Anti-VEGF Aptamer.

Nan Zhao, Mark R Battig, Ming Xu, Xiuli Wang, Na Xiong, Yong Wang

Abstract read
In one paragraph

Article in Macromolecular bioscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Gene therapy to enhance angiogenesis in chronic wounds.Molecular therapy. Nucleic acids · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Affinity Hydrogels for Protein Delivery.Trends in pharmacological sciences · 2021
    Review
  10. Article
  11. Review
  12. Development of hydrogel-like biomaterials via nanoparticle assembly and solid-hydrogel transformation.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Programmable hydrogels.Biomaterials · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nan ZhaoDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Mark R BattigDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Ming XuCenter for Molecular Immunology and Infectious Disease, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Xiuli WangCollege of Basic Medical Science, Dalian Medical University, Dalian, 116044, China.
Na XiongCenter for Molecular Immunology and Infectious Disease, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Yong WangDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.

Funding

Molecularly regulated release of angiogenic factors from superporous hydrogelsR01HL122311 · NHLBI · PENNSYLVANIA STATE UNIVERSITY, THE · PI WANG, YONG · 2015 to 2023
$4.2M
NHLBI NIH HHS R01 HL122311
6 · The paper itself

Abstract

Synthetic molecular libraries hold great potential to advance the biomaterial development. However, little effort is made to integrate molecules with molecular recognition abilities selected from different libraries into a single biomolecular material. The purpose of this work is to incorporate peptides and nucleic acid aptamers into a porous hydrogel to develop a dual-functional biomaterial. The data show that an anti-integrin peptide can promote the attachment and growth of endothelial cells in a 3D porous poly(ethylene glycol) hydrogel and an antivascular endothelial growth factor aptamer can sequester and release VEGF of high bioactivity. Importantly, the dual-functional porous hydrogel enhances the growth and survival of endothelial cells. This work demonstrates that molecules selected from different synthetic libraries can be integrated into one system for the development of novel biomaterials.

Indexed as

Aptamers, PeptideBiocompatible MaterialsCell AdhesionCell ProliferationDelayed-Action PreparationsDrug LiberationHumansHuman Umbilical Vein Endothelial CellsHydrogel, Polyethylene Glycol DimethacrylateOligopeptidesPolyethylene GlycolsPorosityVascular Endothelial Growth Factor AAptamers, Peptidearginyl-glycyl-aspartic acidBiocompatible MaterialsDelayed-Action PreparationsHydrogel, Polyethylene Glycol DimethacrylateOligopeptidesPolyethylene GlycolsVascular Endothelial Growth Factor Aaptamerendothelial cellhydrogelRGD peptidevascular endothelial growth factor

Identifiers

PMID28809082
PMCPMC5685870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.